Skip to content
Home/Companies/MedTech/Micromed
MI

Micromed

MedTech·France·Exited 2023·Held 7yr

Micromed is a MedTech company, headquartered in France.

Entry
2016
Hold
7yr
Exit
2023
Est. EV
–

Who owns Micromed?

Micromed was owned by ARCHIMED through MED I (2014 vintage) from 2016 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
Stago
Active
MedTechFrance· 2026
Fytexia
Exited 2023
HealthTechFrance· 2016
to
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
APEX Digital
Active
Generis Capital PartnersFrance· 2025
Data refreshed weekly · Sourced from public filings